The Foursquare Framework for investing in HealthTech based on Medicine Needs and Social Needs
Lloyd Price
JULY 30, 2018
In his view, venture capital often lean towards the therapeutics companies that fit into the low social complexity/high medical complexity quadrant, such as costly novel drugs for cancer or diabetes. In January, a single therapy to treat a rare form of blindness received a price tag of $850,000. Who's left out?
84 
Let's personalize your content